DRAIC and lung carcinoma: In both LUAD and LUSC, we observed a significant (p < 0.01) poor survival outcome for patients with a low DRAIC and low SBK1 expression compared to the rest of the samples (Figure 5), implying that the DRAIC-SBK1 axis (predicted ceRNA interaction) consistently promotes lung cancer progression.